Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial
Servicios
Servicios
Fecha de publicación
2013Título de revista
Annals of the rheumatic diseases
Tipo de contenido
Publicación de congreso
